The quality of reporting of randomized controlled trials of HuatuoZaizao pill for stroke

Background: HuatuoZaizao pill (HZP), a Chinese patent medicine, is often used in the treatment of stroke. However, there is still a lack of enough evidence to recommend the routine use of HZP for stroke. This study is aimed at evaluating the quality of reporting of randomized controlled trials (RCTs...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Jie, Wang, Yi-Jing, Lu, Xiao, Ying, Peng-Jie, Qian, Shi-Yan, Liang, Jie, Zheng, Guo-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871376/
https://www.ncbi.nlm.nih.gov/pubmed/36703753
http://dx.doi.org/10.3389/fphar.2022.1106957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871376/
https://www.ncbi.nlm.nih.gov/pubmed/36703753
http://dx.doi.org/10.3389/fphar.2022.1106957

Ejemplares similares